Are you Dr. Duerr?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 54 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
4901 Grande Dr
Pensacola, FL 32504Phone+1 850-477-7042Fax+1 850-474-9060
Summary
- Dr. Ann Duerr, MD is a board certified anesthesiologist in Pensacola, Florida. She is currently licensed to practice medicine in Florida. She is affiliated with Ascension Sacred Heart Pensacola.
Education & Training
- University of FloridaResidency, Internal Medicine, 1981 - 1983
- MedStar Health (Baltimore)Internship, Internal Medicine, 1980 - 1981
- University of Florida College of MedicineClass of 1980
Certifications & Licensure
- FL State Medical License 1982 - 2026
- American Board of Anesthesiology Anesthesiology
Clinical Trials
- Expanded Characterization of Immune Response to Merck Adenovirus 5 Gag/Pol/Nef Vaccine Given to HIV Uninfected Adults Start of enrollment: 2007 Jul 01
- HIV Test and Treat to Prevent HIV Transmission Among MSM and Transgender Women Start of enrollment: 2013 Jul 01
Publications & Presentations
PubMed
- 1322 citationsEfficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial.Susan Buchbinder, Devan V. Mehrotra, Ann Duerr, Daniel W. Fitzgerald, Robin Mogg
Lancet. 2008-11-29 - 56 citationsBreast milk and HIV-1: vector of transmission or vehicle of protection?Athena P. Kourtis, Salvatore T. Butera, Chris C. Ibegbu, Laurent Bélec, Ann Duerr
The Lancet. Infectious Diseases. 2003-12-01 - 243 citationsPrevalence, incidence, and type-specific persistence of human papillomavirus in human immunodeficiency virus (HIV)-positive and HIV-negative women.Linda Ahdieh, Robert S. Klein, Robert D. Burk, Susan Cu-Uvin, Paula Schuman
The Journal of Infectious Diseases. 2001-09-15
Press Mentions
- Safety, Acceptability, and Pharmacokinetics of a Monoclonal Antibody-Based Vaginal Multipurpose Prevention Film (MB66): A Phase I Randomized TrialFebruary 3rd, 2021
- ULACNet to Conduct Clinical Trials to Determine if HPV Vaccine Can Reduce HPV Cancer Risks for HIV Positive MenOctober 14th, 2019
- Trial Vaccine Made Some More Vulnerable to H.I.V., Study ConfirmsMay 18th, 2012
- Join now to see all